Zydus Lifesciences Ltd
Announcement under Regulation 30 (LODR)-Press Release / Media Release
⚡ AI Financial Summary & Key Highlights
**Zydus Lifesciences Ltd** announced that a USFDA inspection of its pharmacovigilance and post-marketing systems at its USA office has concluded with nil observations.
Filing Details / Description
USFDA inspection of pharmacovigilance and post marketing system concludes at Zydus'' USA Office with nil observations.